Quan Hao

1.4k total citations
37 papers, 994 citations indexed

About

Quan Hao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Quan Hao has authored 37 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Quan Hao's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (6 papers). Quan Hao is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (6 papers). Quan Hao collaborates with scholars based in China, United States and Taiwan. Quan Hao's co-authors include Jing Tian, Xin Fu, Ying Chen, Wenxin Liu, Lei Zhang, Wu Huijuan, Ke Wang, Yanrui Zhao, Zhibin Hu and Ying Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Quan Hao

31 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quan Hao China 18 659 574 167 129 94 37 994
Zhihong Ai China 12 427 0.6× 275 0.5× 117 0.7× 65 0.5× 88 0.9× 23 648
Wenxing Qin China 17 437 0.7× 283 0.5× 171 1.0× 60 0.5× 95 1.0× 30 780
Lan Dai China 16 404 0.6× 233 0.4× 90 0.5× 112 0.9× 150 1.6× 39 701
Shengsheng Yang China 17 396 0.6× 312 0.5× 78 0.5× 52 0.4× 61 0.6× 34 734
Elisabeth Smolle Austria 12 329 0.5× 237 0.4× 146 0.9× 67 0.5× 47 0.5× 21 639
Chae Young Han Canada 11 399 0.6× 225 0.4× 98 0.6× 88 0.7× 47 0.5× 13 593
Sufang Wu China 18 484 0.7× 325 0.6× 103 0.6× 25 0.2× 116 1.2× 39 725
Tadashi Hayasaka Japan 8 287 0.4× 129 0.2× 185 1.1× 105 0.8× 56 0.6× 16 511
Songshu Xiao China 18 280 0.4× 122 0.2× 124 0.7× 122 0.9× 99 1.1× 46 810
Steven W. Remmenga United States 13 347 0.5× 83 0.1× 157 0.9× 82 0.6× 89 0.9× 20 720

Countries citing papers authored by Quan Hao

Since Specialization
Citations

This map shows the geographic impact of Quan Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Hao more than expected).

Fields of papers citing papers by Quan Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quan Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Hao. The network helps show where Quan Hao may publish in the future.

Co-authorship network of co-authors of Quan Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Quan Hao. A scholar is included among the top collaborators of Quan Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Hao. Quan Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Quan, Wei Zhou, Xinjia Li, et al.. (2025). Precise acoustic field establishment by holography-modulated acoustic intensity. Ultrasonics. 157. 107781–107781.
2.
3.
Huang, Liangyu, Min Liu, Yuying Zhang, et al.. (2024). Higher CSF sTREM2 attenuates APOE ε4 ‐related risk for amyloid pathology in cognitively intact adults: The CABLE study. Journal of Neurochemistry. 169(1). e16273–e16273. 3 indexed citations
4.
Hao, Quan, Shina Li, Jianguo Si, et al.. (2024). Electronic, phononic, and superconducting properties of FeH x ( x = 1–6) at 150 GPa. Journal of Materials Chemistry C. 13(2). 928–937.
5.
Ju, Baohui, Jianghua Wu, Chunrui Yang, et al.. (2023). Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern. International Journal of Gynecological Pathology. 43(3). 233–241. 4 indexed citations
6.
7.
Tian, Jing, Lei Cheng, Yuanyuan Jiang, et al.. (2022). linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer. Reproductive Biology and Endocrinology. 20(1). 132–132. 23 indexed citations
8.
Tian, Jing, Xiangyu Wang, Cherry Yin‐Yi Chang, et al.. (2020). <p>RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis</p>. OncoTargets and Therapy. Volume 13. 3061–3071. 9 indexed citations
9.
Tian, Jing, et al.. (2019). <p>LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer</p>. OncoTargets and Therapy. Volume 12. 8947–8954. 14 indexed citations
10.
Ju, Baohui, Jianmei Wang, Bo Yang, et al.. (2017). Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma. International Journal of Gynecological Pathology. 37(4). 388–396. 26 indexed citations
11.
Tian, Jing, et al.. (2015). MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer. Tumor Biology. 37(1). 239–251. 44 indexed citations
12.
Huijuan, Wu, Zhenghua Xiao, Hua Zhang, et al.. (2014). MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3. Anti-Cancer Drugs. 25(7). 799–809. 47 indexed citations
13.
Huang, Yu-Ting, Baohui Ju, Jing Tian, et al.. (2014). Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening. Oncology Reports. 31(3). 1235–1248. 26 indexed citations
14.
Liu, Xiangyu, et al.. (2014). Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells. Molecular Medicine Reports. 11(3). 1745–1751. 7 indexed citations
15.
Chen, Ying, Lei Zhang, & Quan Hao. (2013). Olaparib: a promising PARP inhibitor in ovarian cancer therapy. Archives of Gynecology and Obstetrics. 288(2). 367–374. 33 indexed citations
16.
Chen, Ying, Lei Zhang, Jing Tian, Xiubao Ren, & Quan Hao. (2013). Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients. Cancer Cell International. 13(1). 6–6. 45 indexed citations
17.
Chen, Ying, Lei Zhang, & Quan Hao. (2013). Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation. Cancer Cell International. 13(1). 86–86. 31 indexed citations
18.
Chen, Ying, Lei Zhang, Jing Tian, et al.. (2012). Significance of the Absolute Number and Ratio of Metastatic Lymph Nodes in Predicting Postoperative Survival for the International Federation of Gynecology and Obstetrics Stage IA2 to IIA Cervical Cancer. International Journal of Gynecological Cancer. 23(1). 157–163. 36 indexed citations
19.
Qiu, Yuanyuan, Ying Chen, Xin Fu, et al.. (2010). HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro. Medical Oncology. 29(1). 358–363. 12 indexed citations
20.
Hao, Quan, Yong Xu, Wenlu Li, Xiaoge Zhao, & Wenxin Liu. (2005). Laser Capture Microdissection Combined with RNA in vitro Linear Amplification Detecting the Relevant Genes of Bladder Cancer. The Chinese-German Journal of Clinical Oncology. 4(5). 309–313. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhihong Ai Breakdown of academic impact, for papers by Wenxing Qin Breakdown of academic impact, for papers by Lan Dai Breakdown of academic impact, for papers by Shengsheng Yang Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Chae Young Han Breakdown of academic impact, for papers by Sufang Wu Breakdown of academic impact, for papers by Tadashi Hayasaka Breakdown of academic impact, for papers by Songshu Xiao Breakdown of academic impact, for papers by Steven W. Remmenga
Rankless by CCL
2026